Novo Nordisk A/S Share Repurchase Programme Update

Novo Nordisk A/S has provided an update on its share repurchase program, initiated on May 6, 2026, in accordance with EU regulations. The program aims to repurchase B shares up to DKK 11,200,000,010.45 between May 6, 2026, and February 1, 2027. As of September 11, 2026, the company has repurchased a total of 18,325,000 B shares for an accumulated value of DKK 5,526,186,488. Novo Nordisk currently holds 47,124,876 B shares as treasury shares, representing 1.1% of the total share capital. The company expects to repurchase B shares totaling up to DKK 15 billion over a 12-month period starting February 4, 2026. To date, since February 4, 2026, 33,084,179 B shares have been repurchased at an average price of DKK 281.89 per share, amounting to DKK 9,326,186,478.